Legislation
- Title
- Investigational Drugs, Biological Products, and Devices - Right to Try Act
- Sponsored by
- Delegates K. Young, Pena-Melnyk, Anderton, Frush, Grammer, Gutierrez, Hixson, Jalisi, Kaiser, Krebs, Lierman, Lisanti, McComas, McCray, McMillan, Metzgar, Rose, Turner, Vogt, Angel, Barron, Bromwell, Cullison, Hayes, Hill, Kelly, Kipke, Miele, Morales, Morgan, Pendergrass, Platt, Rosenberg, Saab, Sample-Hughes, Szeliga, and West
- Status
- Approved by the Governor - Chapter 771
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; requiring a manufacturer of an investigational drug, biological product, or device to notify a specified patient and a specified health care provider of specified side effects or risks; requiring the Office of the Attorney General to develop an informed consent form that meets specified requirements; etc.
Committees
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
21-2B-01 through 21-2B-06 )
Last Updated: 2/3/2020 2:30 PM